James P. Mitchum - Net Worth and Insider Trading
James P. Mitchum Net Worth
The estimated net worth of James P. Mitchum is at least $5 dollars as of 2024-11-13. James P. Mitchum is the Director of Tenax Therapeutics Inc and owns about 1 shares of Tenax Therapeutics Inc (TENX) stock worth over $5. Details can be seen in James P. Mitchum's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James P. Mitchum has not made any transactions after 2016-02-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James P. Mitchum
James P. Mitchum Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James P. Mitchum owns 2 companies in total, including Tenax Therapeutics Inc (TENX) , and NephroGenex Inc (NRXGQ) .
Click here to see the complete history of James P. Mitchum’s form 4 insider trades.
Insider Ownership Summary of James P. Mitchum
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TENX | Tenax Therapeutics Inc | 2016-11-21 | director |
| NRXGQ | NephroGenex Inc | 2015-04-30 | director |
James P. Mitchum Latest Holdings Summary
James P. Mitchum currently owns a total of 1 stock. James P. Mitchum owns 1 shares of Tenax Therapeutics Inc (TENX) as of February 3, 2016, with a value of $5.
Latest Holdings of James P. Mitchum
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TENX | Tenax Therapeutics Inc | 2016-02-03 | 1 | 4.94 | 5 |
Holding Weightings of James P. Mitchum
James P. Mitchum Form 4 Trading Tracker
According to the SEC Form 4 filings, James P. Mitchum has made a total of 0 transactions in Tenax Therapeutics Inc (TENX) over the past 5 years. The most-recent trade in Tenax Therapeutics Inc is the acquisition of 1 shares on February 3, 2016, which cost James P. Mitchum around $50,540.
Insider Trading History of James P. Mitchum
- 1
James P. Mitchum Trading Performance
GuruFocus tracks the stock performance after each of James P. Mitchum's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James P. Mitchum is 4.91%. GuruFocus also compares James P. Mitchum's trading performance to market benchmark return within the same time period. The performance of stocks bought by James P. Mitchum within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James P. Mitchum's insider trading performs compared to the benchmark.
Performance of James P. Mitchum
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -19.62 | | | | | |
| Relative Return to S&P 500(%) | -23.85 | | | | | |
James P. Mitchum Ownership Network
Ownership Network List of James P. Mitchum
Ownership Network Relation of James P. Mitchum
James P. Mitchum Owned Company Details
What does Tenax Therapeutics Inc do?
Who are the key executives at Tenax Therapeutics Inc?
James P. Mitchum is the director of Tenax Therapeutics Inc. Other key executives at Tenax Therapeutics Inc include Interim CFO Eliot M Lurier , director & CEO Chrisopher Thomas Giordano , and Chief Medical Officer Stuart Rich .
Tenax Therapeutics Inc (TENX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Tenax Therapeutics Inc (TENX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tenax Therapeutics Inc (TENX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Tenax Therapeutics Inc (TENX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tenax Therapeutics Inc Insider Transactions
James P. Mitchum Mailing Address
Above is the net worth, insider trading, and ownership report for James P. Mitchum. You might contact James P. Mitchum via mailing address: C/o Nephrogenex, Inc., 79 T.w. Alexander Drive, Research Triangle Park Nc 27709.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
